Establishment Labs Holdings ROA 2017-2024 | ESTA
Current and historical return on assets (ROA) values for Establishment Labs Holdings (ESTA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Establishment Labs Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $-0.07B | $0.28B | -24.93% |
| 2024-06-30 | $-0.08B | $0.29B | -29.46% |
| 2024-03-31 | $-0.08B | $0.30B | -29.46% |
| 2023-12-31 | $-0.08B | $0.27B | -30.56% |
| 2023-09-30 | $-0.07B | $0.27B | -29.51% |
| 2023-06-30 | $-0.06B | $0.29B | -27.77% |
| 2023-03-31 | $-0.08B | $0.21B | -40.59% |
| 2022-12-31 | $-0.08B | $0.21B | -41.03% |
| 2022-09-30 | $-0.08B | $0.19B | -45.37% |
| 2022-06-30 | $-0.07B | $0.20B | -45.71% |
| 2022-03-31 | $-0.04B | $0.14B | -27.49% |
| 2021-12-31 | $-0.04B | $0.14B | -27.70% |
| 2021-09-30 | $-0.03B | $0.15B | -21.71% |
| 2021-06-30 | $-0.02B | $0.15B | -14.31% |
| 2021-03-31 | $-0.03B | $0.15B | -17.42% |
| 2020-12-31 | $-0.04B | $0.16B | -23.90% |
| 2020-09-30 | $-0.04B | $0.16B | -25.46% |
| 2020-06-30 | $-0.05B | $0.16B | -33.57% |
| 2020-03-31 | $-0.05B | $0.17B | -36.22% |
| 2019-12-31 | $-0.04B | $0.12B | -34.74% |
| 2019-09-30 | $-0.04B | $0.12B | -39.20% |
| 2019-06-30 | $-0.03B | $0.11B | -26.55% |
| 2019-03-31 | $-0.03B | $0.11B | -25.37% |
| 2018-12-31 | $-0.02B | $0.12B | -24.44% |
| 2018-09-30 | $-0.02B | $0.12B | -24.00% |
| 2018-06-30 | $-0.03B | $0.06B | -67.04% |
| 2018-03-31 | $-0.04B | $0.06B | -127.59% |
| 2017-12-31 | $-0.04B | $0.06B | -245.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.848B | $0.165B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.685B | 28.04 |
| Elevance Health (ELV) | United States | $90.559B | 11.84 |
| Cencora (COR) | United States | $47.572B | 17.32 |
| Natera (NTRA) | United States | $23.122B | 0.00 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| ICON (ICLR) | Ireland | $16.164B | 14.40 |
| Avantor (AVTR) | United States | $14.769B | 22.14 |
| Revvity (RVTY) | United States | $14.502B | 24.32 |
| BioMerieux (BMXMF) | France | $14.256B | 0.00 |
| Viatris (VTRS) | United States | $13.010B | 4.01 |
| Solventum (SOLV) | United States | $12.919B | 0.00 |
| CochLear (CHEOY) | Australia | $12.848B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
| Doximity (DOCS) | United States | $10.877B | 56.56 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
| HealthEquity (HQY) | United States | $9.712B | 48.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
| BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
| Sotera Health (SHC) | United States | $3.909B | 20.91 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
| Concentras Parent (CON) | United States | $2.958B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
| PACS (PACS) | United States | $2.161B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
| Progyny (PGNY) | United States | $1.859B | 37.64 |
| GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
| Premier (PINC) | United States | $1.821B | 11.08 |
| GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.351B | 0.00 |
| CareDx (CDNA) | United States | $1.217B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
| Embecta (EMBC) | United States | $1.031B | 7.06 |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
| SBC Medicals (SBC) | United States | $0.533B | 0.00 |
| DocGo (DCGO) | United States | $0.501B | 18.89 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 35.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| Nutex Health (NUTX) | United States | $0.323B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
| LifeMD (LFMD) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.201B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| ModivCare (MODV) | United States | $0.062B | 3.35 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |